Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Drug Resistance

Free Subscription 15.12.2025 17 Antimicrob Agents Chemother 1 BMJ 2 Emerg Infect Dis 1 Infect Control Hosp Epidemiol 1 Int J Antimicrob Agents 3 J Med Microbiol 1 PLoS Med 6 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antimicrob Agents Chemother

1. TAKEI K, Kanamori H, Sakata R, Ogawa M, et al
   High-risk clonal expansion of IMP-producing Enterobacter cloacae complex in regional Japanese healthcare settings.
   Antimicrob Agents Chemother. 2025;69:e0095325.
   PubMed         Abstract available
   
   
2. MARCH VFA, Zwyer M, Loiseau C, Brites D, et al
   Variability in intrinsic drug tolerance in Mycobacterium tuberculosis corresponds with phylogenetic lineage.
   Antimicrob Agents Chemother. 2025 Oct 21:e0099625. doi: 10.1128/aac.00996.
   PubMed         Abstract available
   
   
3. COOPER K, Murthy K, Balzer T, Parkinson S, et al
   In vitro and in vivo characterization of Bisphosphocin Nu-3-a novel broad-spectrum antimicrobial compound with high potency against resistant pathogens.
   Antimicrob Agents Chemother. 2025;69:e0094825.
   PubMed         Abstract available
   
   
4. SUN L, Lei T, Liu Y, Lu S, et al
   In vivo development of elevated linezolid resistance mediated by a deletion in ribosomal protein L3 in clinical Enterococcus faecium.
   Antimicrob Agents Chemother. 2025 Oct 28:e0087125. doi: 10.1128/aac.00871.
   PubMed         Abstract available
   
   
5. KENT JE, Elane M, Leyn S, Zlamal J, et al
   Mutations in two-component signaling systems drive experimental evolution of tigecycline and colistin resistance in Acinetobacter baumannii.
   Antimicrob Agents Chemother. 2025;69:e0080925.
   PubMed         Abstract available
   
   
6. VANACHAYANGKUL P, Ruamsap N, Caridha D, Imerbsin R, et al
   Preclinical in vitro and in vivo evaluation of omadacycline against multidrug-resistant Acinetobacter baumannii.
   Antimicrob Agents Chemother. 2025;69:e0093225.
   PubMed         Abstract available
   
   
7. HODBERT E, Lemenand O, Thibaut S, Coeffic T, et al
   Exploring multidrug resistance patterns in community-acquired Escherichia coli urinary tract infections with machine learning.
   Antimicrob Agents Chemother. 2025 Oct 31:e0042225. doi: 10.1128/aac.00422.
   PubMed         Abstract available
   
   
8. FU Y, Zhang Y, Zhao J, Xie J, et al
   Emergence of co-resistance to imipenem/relebactam and ceftazidime/avibactam in clinical Klebsiella pneumoniae ST11 clone due to KPC-2 N132S and CTX-M-65 S130G/P167S substitutions.
   Antimicrob Agents Chemother. 2025;69:e0089125.
   PubMed         Abstract available
   
   
9. MOHAMAD M, Hurst MM, Elkrewi E, Randall CP, et al
   Nature of bacitracin resistance in Staphylococcus aureus.
   Antimicrob Agents Chemother. 2025 Nov 4:e0087525. doi: 10.1128/aac.00875.
   PubMed         Abstract available
   
   
10. WANGCHINDA W, Wu JY, Abbo LM, Ackley R, et al
    Effectiveness of imipenem-relebactam for multidrug-resistant Pseudomonas aeruginosa in pneumonia and bloodstream infections in the United States (MIRAGE).
    Antimicrob Agents Chemother. 2025;69:e0132525.
    PubMed         Abstract available
    
    
11. ALVARADO-OROSCO N, Gomis-Font MA, Sastre-Femenia MA, Ribera Ortiz S, et al
    First nationwide survey on Pseudomonas aeruginosa in Bolivia: susceptibility profiles, resistome, and genomic epidemiology.
    Antimicrob Agents Chemother. 2025;69:e0116325.
    PubMed         Abstract available
    
    
12. HUSSEIN M, Crawford S, Baker M, Floyd H, et al
    Hyperforin potentiates polymyxin B against multidrug-resistant Gram-negative pathogens via membrane disruption, biofilm eradication, and oxidative stress.
    Antimicrob Agents Chemother. 2025;69:e0100725.
    PubMed         Abstract available
    
    
13. HESELPOTH RD, Euler CW, Fischetti VA
    Second-generation lysocins as therapeutics for treating Pseudomonas aeruginosa infections.
    Antimicrob Agents Chemother. 2025;69:e0131225.
    PubMed         Abstract available
    
    
14. CADENAS-JIMENEZ I, Gonzalez-Diaz A, Berbel D, Costa-Primo R, et al
    First report of a DIM-1-producing Pseudomonas aeruginosa in Spain: genomic characterization and resistance determinants.
    Antimicrob Agents Chemother. 2025;69:e0131125.
    PubMed         Abstract available
    
    
15. NODARI CS, Bai Q, Cayo R, Streling AP, et al
    ISAba1-mediated bla(ADC) disruption restores third-generation cephalosporin susceptibility in a clinical Acinetobacter baumannii isolate.
    Antimicrob Agents Chemother. 2025;69:e0070725.
    PubMed         Abstract available
    
    
16. DARNELL RL, Knottenbelt MK, Rose OE, Cleary CSB, et al
    Prolonged exposure to teixobactin generates cross-tolerance to other cell wall-targeting antimicrobials in Enterococcus faecalis.
    Antimicrob Agents Chemother. 2025 Nov 18:e0062925. doi: 10.1128/aac.00629.
    PubMed         Abstract available
    
    
17. APPLEBACH E, Amburgey-Crovetti K, Bakotic WL, Adhikari TB, et al
    Prevalence and diversity of antifungal resistance in Fusarium isolates across clinical and agricultural settings in the United States.
    Antimicrob Agents Chemother. 2025;69:e0120825.
    PubMed         Abstract available
    
    

    
    BMJ

18. REZA N, Dubey V, Sharland M, Hope W, et al
    Antimicrobial use and resistance.
    BMJ. 2025;391:e082681.
    PubMed         Abstract available
    
    

    
    Emerg Infect Dis

19. SEUNG KJ, Asfaw M, Kunda M, Maama-Maime LB, et al
    Extensively Drug-Resistant Tuberculosis with Conflicting Resistance Testing Results, Lesotho.
    Emerg Infect Dis. 2025;31:2185-2187.
    PubMed         Abstract available
    
    
20. BEALL B, Lin W, Li Z, Tran T, et al
    Two Independent Acquisitions of Multidrug Resistance Gene lsaC in Streptococcus pneumoniae Serotype 20 Multilocus Sequence Type 1257.
    Emerg Infect Dis. 2025;31:2098-2108.
    PubMed         Abstract available
    
    

    
    Infect Control Hosp Epidemiol

21. SINGH HK, Ross B, Hannah J, Ting S, et al
    Hospital-onset methicillin-resistant Staphylococcus aureus bloodstream infections within tertiary and community hospitals and implications for prevention.
    Infect Control Hosp Epidemiol. 2025 Dec 9:1-8. doi: 10.1017/ice.2025.10370.
    PubMed         Abstract available
    
    

    
    Int J Antimicrob Agents

22. XU J, Li Y, Wang Y, Liu F, et al
    Machine-Learning and Gene-Synergy Networks Reveal Interpretable Drivers of Antibiotic Resistance in Staphylococcus aureus.
    Int J Antimicrob Agents. 2025 Dec 10:107690.
    PubMed         Abstract available
    
    

    
    J Med Microbiol

23. FOWLER P, Hawley R, Milbrath MO
    Potential confounding factors in currently used antibiotic susceptibility assays for the honey bee pathogen Melissococcus plutonius.
    J Med Microbiol. 2025;74:002109.
    PubMed         Abstract available
    
    
24. NAKANO S, Fujisawa T, Koide S, Sugawara Y, et al
    Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae in paediatric patients in Japan (2020-2023).
    J Med Microbiol. 2025;74:002105.
    PubMed         Abstract available
    
    
25. WU Z, Li X, Dou X, Yang H, et al
    Targeted detection of Helicobacter pylori resistance to clarithromycin and levofloxacin using single-cell Raman spectroscopy.
    J Med Microbiol. 2025;74:002094.
    PubMed         Abstract available
    
    

    
    PLoS Med

26. MCLAUGHLIN A, Toy J, Montoya V, Sereda P, et al
    Heterogeneous impacts of HIV pre-exposure prophylaxis (PrEP) on drug resistance and phylogenetic cluster transmission dynamics in British Columbia, Canada: A retrospective cohort and simulation study.
    PLoS Med. 2025;22:e1004827.
    PubMed         Abstract available
    
    

    
    PLoS One

27. RAHMAN MS, Islam MT, Hasan M, Tariquzzaman M, et al
    Whole-genome analysis of Lysinibacillus boronitolerans MSR1: A dairy-isolated multidrug-resistant and non-pathogenic strain.
    PLoS One. 2025;20:e0333844.
    PubMed         Abstract available
    
    
28. GETIE M, Tafere W, Tsega A, Gebreyesus T, et al
    Antimicrobial resistance profiles of bacteria from clinical specimens at Amhara Public Health Institute, Bahir Dar, Ethiopia: A retrospective study.
    PLoS One. 2025;20:e0337332.
    PubMed         Abstract available
    
    
29. HACKMAN HK, Annison L, Arhin RE, Aidoo EK, et al
    Awareness of antimicrobial resistance and antibiotic use among poultry farmers in Accra, Ghana: A cross-sectional survey.
    PLoS One. 2025;20:e0337531.
    PubMed         Abstract available
    
    
30. MOHAMMED FA, Sarkar R, Ayele F, Urgesa K, et al
    Nasopharyngeal carriage of Streptococcus pneumoniae, its associated factors, and antimicrobial susceptibility patterns among school children in Babile district, eastern Ethiopia.
    PLoS One. 2025;20:e0337950.
    PubMed         Abstract available
    
    
31. KATEETE DP, Namakula S, Kigozi E, Katabazi FA, et al
    Patterns of compensatory mutations in rpoA/B/C genes of multidrug resistant M. tuberculosis in Uganda.
    PLoS One. 2025;20:e0328957.
    PubMed         Abstract available
    
    
32. HUSSEIN AM, Muhialdin AJ, Faraj RK
    Prevalence of antibiotic-resistant Escherichia coli isolates from healthy chicken droppings.
    PLoS One. 2025;20:e0337055.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.